Biotrial
Full‑service contract research organization (CRO) founded in 1989. Provides integrated drug‑development services spanning preclinical pharmacology, early‑phase clinical development (including Phase I), bioanalysis and sample management, biometrics and data management, centralized core laboratory services for electrophysiology, cardiac safety and medical imaging, and data science (modeling, simulation and AI). Operates GLP/AAALAC‑accredited preclinical facilities and clinical pharmacology units in France and the USA, with additional presence in the UK and Canada.
Industries
N/A
Nr. of Employees
small (1-50)
Services
In vitro and in vivo efficacy, safety pharmacology, PK studies, model development and translational assays for drug discovery and preclinical development.
Design and conduct of first‑in‑human and early‑phase studies with healthy volunteers and special populations in dedicated clinical pharmacology units.
Quantitative bioanalytical method development and GLP‑compliant sample analysis with controlled sample receipt, chain‑of‑custody, cold storage and continuous temperature monitoring.
Centralized management and expert analysis of electrophysiology (EEG/polysomnography), CNS endpoints, cardiac safety (ECG/QT) and medical imaging (MRI, PET). Includes image acquisition coordination with hospital partners, certified device expertise, endpoint centralization, and site training/support throughout the study lifecycle.
Statistical programming, clinical data management and validated RTSM implementation to integrate randomization, supply management and EDC workflows.
Modeling and simulation (population PK, PK/PD, PBPK, QSP), in‑silico trials, machine learning and real‑world data integration to inform trial design, sample size and external control strategies.
In vitro and in vivo efficacy, safety pharmacology, PK studies, model development and translational assays for drug discovery and preclinical development.
Design and conduct of first‑in‑human and early‑phase studies with healthy volunteers and special populations in dedicated clinical pharmacology units.
Quantitative bioanalytical method development and GLP‑compliant sample analysis with controlled sample receipt, chain‑of‑custody, cold storage and continuous temperature monitoring.
Centralized management and expert analysis of electrophysiology (EEG/polysomnography), CNS endpoints, cardiac safety (ECG/QT) and medical imaging (MRI, PET). Includes image acquisition coordination with hospital partners, certified device expertise, endpoint centralization, and site training/support throughout the study lifecycle.
Statistical programming, clinical data management and validated RTSM implementation to integrate randomization, supply management and EDC workflows.
Modeling and simulation (population PK, PK/PD, PBPK, QSP), in‑silico trials, machine learning and real‑world data integration to inform trial design, sample size and external control strategies.
Expertise Areas
- Clinical trial management (early‑phase/Phase I)
- Preclinical pharmacology and model development
- Bioanalysis and sample management
- Data science and pharmacometrics (modeling & simulation)
Key Technologies
- Liquid chromatography‑tandem mass spectrometry (LC‑MS/MS)
- Immunoassays (ELISA)
- Laboratory Information Management Systems (LIMS)
- Validated RTSM and integrated RTSM‑EDC randomization and trial supply systems
News & Updates
On‑site open‑house events for sponsors to tour the Phase I facility and review core lab workshops (EEG) and unit capabilities.
Summary of Data Science department activities including modeling & simulation, PopPK, PBPK, machine learning projects and AI‑driven automation applied to clinical research.
Expanded collaboration to integrate immunology bioassays, single‑cell omics and omics‑driven data science to support translational oncology and cell therapy characterization.
Accreditation demonstrating validated capability in randomization and trial supply management integrated with EDC.
Passed FDA Bioresearch Monitoring inspection for compliance with standards protecting subject rights and ensuring data reliability.
On‑site open‑house events for sponsors to tour the Phase I facility and review core lab workshops (EEG) and unit capabilities.
Summary of Data Science department activities including modeling & simulation, PopPK, PBPK, machine learning projects and AI‑driven automation applied to clinical research.
Expanded collaboration to integrate immunology bioassays, single‑cell omics and omics‑driven data science to support translational oncology and cell therapy characterization.
Accreditation demonstrating validated capability in randomization and trial supply management integrated with EDC.
Passed FDA Bioresearch Monitoring inspection for compliance with standards protecting subject rights and ensuring data reliability.